10th week of 2021 patent applcation highlights part 25 |
Patent application number | Title | Published |
20210070736 | HIERARCHICAL NANOPOROUS DIAMONDOID SUPERSTRUCTURE | 2021-03-11 |
20210070737 | ANTIVIRAL COMPOUNDS AND USE THEREOF | 2021-03-11 |
20210070738 | POLYCRYSTALLINE FORM OF DEHYDROPHENYLAHISTIN-LIKE COMPOUND, AND MANUFACTURING AND PURIFICATION METHOD AND APPLICATION THEREOF | 2021-03-11 |
20210070739 | 2-BENZOPYRAZINYL-N-HETEROARYL-2-PHENYL-ACETAMIDE COMPOUNDS | 2021-03-11 |
20210070740 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE ORGANIC COMPOUND | 2021-03-11 |
20210070741 | Mechanochemical Regulation of a Photochemical Reaction | 2021-03-11 |
20210070742 | SULFOXIMINE, SULFONIMIDAMIDE, SULFONDIIMINE AND DIIMIDOSULFONAMIDE COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE | 2021-03-11 |
20210070743 | RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME | 2021-03-11 |
20210070744 | HETEROCYCLIC RIP1 KINASE INHIBITORS | 2021-03-11 |
20210070745 | SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | 2021-03-11 |
20210070746 | 5-(PYRIMIDIN-4-YL)THIAZOL-2-YL UREA DERIVATIVES AS THERAPEUTIC AGENTS | 2021-03-11 |
20210070747 | 2(1H)-QUINOLINONE DERIVATIVE | 2021-03-11 |
20210070748 | INHIBITORS OF BRUTONS TYROSINE KINASE | 2021-03-11 |
20210070749 | PROCESS FOR THE PREPARATION OF A MEDICAMENT | 2021-03-11 |
20210070750 | HALO-ALLYLAMINE SSAO/VAP-1 INHIBITOR AND USE THEREOF | 2021-03-11 |
20210070751 | SUBSTITUTED INDOLE ETHER COMPOUNDS | 2021-03-11 |
20210070752 | HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS | 2021-03-11 |
20210070753 | HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING AGENT CONTAINING SAME | 2021-03-11 |
20210070754 | JAK INHIBITOR AND USE THEREOF | 2021-03-11 |
20210070755 | METHOD FOR THE PRODUCTION OF LUMATEPERONE AND ITS SALTS | 2021-03-11 |
20210070756 | TETRACYCLIC BROMODOMAIN INHIBITORS | 2021-03-11 |
20210070757 | BRAF INHIBITORS AND USE THEREOF FOR TREATMENT OF CUTANEOUS REACTIONS | 2021-03-11 |
20210070758 | FUSED BICYCLIC COMPOUND FOR INHIBITING ACTIVITY OF TYROSINE KINASE | 2021-03-11 |
20210070759 | CRYSTALLINE FORMS OF A BRUTONS TYROSINE KINASE INHIBITOR | 2021-03-11 |
20210070760 | METHOD FOR PREPARING PARP INHIBITOR AND INTERMEDIATE THEREOF | 2021-03-11 |
20210070761 | CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS | 2021-03-11 |
20210070762 | SYNTHESIS OF COELENTERAZINE | 2021-03-11 |
20210070763 | SPIROCYCLIC COMPOUNDS | 2021-03-11 |
20210070764 | TRICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF | 2021-03-11 |
20210070765 | METAL-FREE SOLVENT-FREE SYNTHESIS OF FUSED-PYRIDO HETEROCYCLES AND BIOMEDICAL APPLICATIONS | 2021-03-11 |
20210070766 | 2,3-DIHYDROFURO[2,3-B]PYRIDINE COMPOUNDS | 2021-03-11 |
20210070767 | APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF | 2021-03-11 |
20210070768 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 2021-03-11 |
20210070769 | SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | 2021-03-11 |
20210070770 | ORGANIC SEMICONDUCTING COMPOUNDS | 2021-03-11 |
20210070771 | COMMERCIALLY VIABLE SYNTHESIS OF CANTHARIDIN AND BIOACTIVE CANTHARIDIN DERIVATIVES | 2021-03-11 |
20210070772 | ANTI-BACTERIAL HETEROCYCLIC COMPOUNDS AND THEIR SYNTHESIS | 2021-03-11 |
20210070773 | 4-HYDROXYPIPERIDINE DERIVATIVES AND THEIR USE AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 19 (USP19) | 2021-03-11 |
20210070774 | PENAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2021-03-11 |
20210070775 | Antitumoral Compounds | 2021-03-11 |
20210070776 | ORGANIC-INORGANIC HYBRID PEROVSKITES | 2021-03-11 |
20210070777 | METHOD FOR SYNTHESIZING ORGANIC MAGNESIUM COMPOUND, METHOD FOR SYNTHESIZING ORGANIC BORONIC ACID COMPOUND, AND COUPLING METHOD | 2021-03-11 |
20210070778 | NOVEL PROCESS FOR THE PREPARATION OF CRISABOROLE AND ITS INTERMEDIATES | 2021-03-11 |
20210070779 | BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS | 2021-03-11 |
20210070780 | Boron-Containing Small Molecules | 2021-03-11 |
20210070781 | A PROCESS FOR THE PREPARATION OF CRISABOROLE | 2021-03-11 |
20210070782 | METHOD FOR SYNTHESIZING BORONATE ESTER COMPOUND, SODIUM SALT OF BORONATE ESTER COMPOUND, AND METHOD FOR SYNTHESIZING THE SAME | 2021-03-11 |
20210070783 | ORGANOMETALLIC COMPOUND AND METHOD | 2021-03-11 |
20210070784 | NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE INHIBITORS AND METHODS FOR USE OF THE SAME | 2021-03-11 |
20210070785 | ENANTIOPURE TERPHENYLS WITH TWO ORTHO-ATROPISOMERIC AXES | 2021-03-11 |
20210070786 | PHOSPHONIUM-BASED ZWITTERIONIC MONOMERS AND POLYMERS, AND COMPOSITIONS AND METHODS THEREOF | 2021-03-11 |
20210070787 | Mito-Honokiol Compounds and Methods of Synthesis and Use Thereof | 2021-03-11 |
20210070788 | Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer | 2021-03-11 |
20210070789 | 3,3,3',3'-TETRAMETHYL-1,1'-SPIROBIINDANE-BASED MONOPHOSPHINE LIGAND, INTERMEDATES TEHREOF, PREPARATION METHOD AND USE OF THE SAME | 2021-03-11 |
20210070790 | BISMUTH COMPOUND, CURABLE COMPOSITION AND CURED PRODUCT | 2021-03-11 |
20210070791 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2021-03-11 |
20210070792 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2021-03-11 |
20210070793 | METHOD FOR PRODUCING TETRAKIS (TRIHYDROCARBYL PHOSPHANE) PALLADIUM(0) | 2021-03-11 |
20210070794 | PRODUCTION METHODS FOR IRON FULVATE SOLUTION, IRON HYDROXIDE FULVATE SOLUTION AND POLYSILICA-IRON FULVATE SOLUTION | 2021-03-11 |
20210070795 | REVERSIBLE MODIFICATION OF NUCLEOTIDES | 2021-03-11 |
20210070796 | MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF | 2021-03-11 |
20210070797 | PROCESSES FOR PREPARING FLUOROKETOLIDES | 2021-03-11 |
20210070798 | Inhibitors of E1 activating enzymes | 2021-03-11 |
20210070799 | COMPOUNDS FOR TREATING NEURODEGENERATIVE DISORDERS | 2021-03-11 |
20210070800 | METHOD OF PRODUCING A TRIPEPTIDE GAMMA-GLU-VAL-GLY USING ENTEROBACTERIACEAE | 2021-03-11 |
20210070801 | NOVEL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2021-03-11 |
20210070802 | SELECTIVE TARGETING OF APOPTOSIS PROTEINS BY STRUCTURALLY-STABILIZED AND/OR CYSTEINE-REACTIVE NOXA PEPTIDES | 2021-03-11 |
20210070803 | MODIFIED PEPTIDES AND ASSOCIATED METHODS OF USE | 2021-03-11 |
20210070804 | MYOTOXIN-NEUTRALIZING PEPTIDES | 2021-03-11 |
20210070805 | CD40 TARGETED PEPTIDES AND USES THEREOF | 2021-03-11 |
20210070806 | CYCLIC CELL-PENETRATING PEPTIDES WITH ONE OR MORE HYDROPHOBIC RESIDUES | 2021-03-11 |
20210070807 | COMPOSITIONS AND METHODS FOR TREATING DISEASES BY INHIBITING EXOSOME RELEASE | 2021-03-11 |
20210070808 | EPITOPE FOCUSING BY VARIABLE EFFECTIVE ANTIGEN SURFACE CONCENTRATION | 2021-03-11 |
20210070809 | NOVEL ANTIBACTERIAL PROTEIN EFAL-2 HAVING BACTERIOLYTIC ABILITY WITH RESPECT TO ENTEROCOCCUS FAECIUM | 2021-03-11 |
20210070810 | COMPOSITIONS AND METHODS USING METHANOTROPHIC S-LAYER PROTEINS FOR EXPRESSION OF HETEROLOGOUS PROTEINS | 2021-03-11 |
20210070811 | METHOD FOR PROTEIN NANOWIRE SYNTHESIS AND TUNABLE CONTROL OF NANOWIRE LENGTH | 2021-03-11 |
20210070812 | FERMENTATION PROCESS | 2021-03-11 |
20210070813 | SALMONELLA SIIE-DERIVED PEPTIDES FOR MANIPULATION OF LONG-LIVED PLASMA CELLS | 2021-03-11 |
20210070814 | MODIFIED PROTEIN | 2021-03-11 |
20210070815 | MUCOADHESIVE MICROORGANISM | 2021-03-11 |
20210070816 | SURFACTANT ADHESIVE COMPOSITION | 2021-03-11 |
20210070817 | ANTICOAGULANT FUSION PROTEINS AND USES THEREOF | 2021-03-11 |
20210070818 | VACCINE COMPOSITIONS AND METHODS OF MAKING SAME | 2021-03-11 |
20210070819 | ANTIGENIC PEPTIDES DERIVING FROM SECRETOGRANIN V AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES | 2021-03-11 |
20210070820 | NFAT BINDING POLYNUCLEOTIDES | 2021-03-11 |
20210070821 | METHOD FOR PREPARING HIGHLY PURE RHNGF | 2021-03-11 |
20210070822 | Method for the Purification of G-CSF | 2021-03-11 |
20210070823 | METHODS AND COMPOSITIONS FOR TREATING ATOPIC DERMATITIS WITH RECOMBINANT MICROORGANISMS | 2021-03-11 |
20210070824 | IL-7-FC-FUSION PROTEINS | 2021-03-11 |
20210070825 | MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF | 2021-03-11 |
20210070826 | MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF | 2021-03-11 |
20210070827 | IL-2 CONJUGATES AND METHODS OF USE TO TREAT AUTOIMMUNE DISEASES | 2021-03-11 |
20210070828 | MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES | 2021-03-11 |
20210070829 | MULTI-DOMAIN ACTIVE PROTEIN FOR TREATING METABOLIC DISEASES | 2021-03-11 |
20210070830 | GENE REGULATION VIA CONDITIONAL NUCLEAR LOCALIZATION OF GENE MODULATING POLYPEPTIDES | 2021-03-11 |
20210070831 | POOLING SIGNALING AND COSTIMULATORY DOMAINS IN FLEXIBLE CAR DESIGN | 2021-03-11 |
20210070832 | ANTIGEN-SPECIFIC HELPER T-CELL RECEPTOR GENES | 2021-03-11 |
20210070833 | EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IGE FC RECEPTOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME AND METHOD FOR PRODUCING SAME | 2021-03-11 |
20210070834 | PEPTIDE-MHC COMPACTS | 2021-03-11 |
20210070835 | UNIVERSAL DONOR CELLS | 2021-03-11 |